Zhengye Biotechnology Holding (ZYBT) Other Non-Current Liabilities (2024 - 2025)
Zhengye Biotechnology Holding's Other Non-Current Liabilities was $12,689 in the quarter ended Dec 31, 2025, down 37.6% from $20,325 a year earlier.
Zhengye Biotechnology Holding (ZYBT) Other Non-Current Liabilities (2024 - 2025) Analysis & Trends
As of Dec 31, 2025, Other Non-Current Liabilities at Zhengye Biotechnology Holding came in at $12,524, down 37.4% from the prior year.
- In earlier years, Other Non-Current Liabilities was $20,000 in the year ended Dec 31, 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Zhengye Biotechnology Holding | 69.19 Mn | 65.60 Mn | - |
Zhengye Biotechnology Holding Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZYBT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ZYBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ZYBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();